TABLE 6.

Variations in Care Bundle Practices Among Participating Hospitals, May 2019 to October 2021

Care BundleItems in the Care BundleReporting Hospitals (N)Initial Control-Line (%)Final Control-Line (%)Variation (percentage points)
MEOWSN/A197898+20
PPH prevention actionsAssess hemorrhage risk16 of 19b92920
Quantify blood loss5790+33
10 IU oxytocin after delivery8099+19
PPH first response care bundleTranexamic acid6 of 76390+27
IV fluids7684+8
Oxytocic drugs (higher dose)7687+11
Uterine massage7489+15
HDP care bundleMagnesium sulfate (loading dose)4 of 886860
Magnesium sulfate (maintenance dose)5475+21
Treat high blood pressurea87870
Sepsis care bundleMeasure lactate level3 of 44288+46
Obtain blood cultures prior to administration of antibiotics84840
Administer antibiotic92920
Rapidly administer 500 ml IV solution5393+40
Apply vasopressor after IV fluid to maintain mean arterial pressure ≥ 65 mmHg91910
  • Abbreviations: HDP, hypertensive disorders of pregnancy; MEOWS, Modified Early Obstetric Warning Score; N/A, not applicable; PPH, postpartum hemorrhage.

  • a Hydralazine was the antihypertensive/vasodilator available in the participating hospitals.

  • b The reporting hospitals varied from 5 to 16, reaching 16 in the last 3 months of the BTS.